Destination Wealth Management Johnson & Johnson Transaction History

Destination Wealth Management

  • $3.19 Billion
  • Q3 2024

A detailed history of Destination Wealth Management transactions in Johnson & Johnson stock. As of the latest transaction made, Destination Wealth Management holds 268,537 shares of JNJ stock, worth $39.3 Million. This represents 1.36% of its overall portfolio holdings.

Number of Shares
268,537
Previous 261,404 2.73%
Holding current value
$39.3 Million
Previous $38.2 Million 13.91%
% of portfolio
1.36%
Previous 1.27%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 25, 2024
BUY
$145.48 - $167.38 $1.04 Million - $1.19 Million
7,133 Added 2.73%
268,537 $43.5 Million
Q2 2024

Jul 24, 2024
BUY
$144.38 - $157.78 $946,555 - $1.03 Million
6,556 Added 2.57%
261,404 $38.2 Million
Q1 2024

May 14, 2024
BUY
$155.22 - $162.74 $1.51 Million - $1.59 Million
9,754 Added 3.98%
254,848 $40.3 Million
Q4 2023

Feb 13, 2024
SELL
$145.6 - $158.88 $902,283 - $984,579
-6,197 Reduced 2.47%
245,094 $38.4 Million
Q3 2023

Nov 14, 2023
BUY
$155.75 - $174.48 $646,674 - $724,440
4,152 Added 1.68%
251,291 $39.1 Million
Q2 2023

Aug 11, 2023
BUY
$154.35 - $166.11 $227,203 - $244,513
1,472 Added 0.6%
247,139 $40.9 Million
Q1 2023

May 05, 2023
BUY
$151.05 - $180.26 $139,268 - $166,199
922 Added 0.38%
245,667 $38.1 Million
Q4 2022

Feb 10, 2023
SELL
$160.2 - $179.79 $796,194 - $893,556
-4,970 Reduced 1.99%
244,745 $43.2 Million
Q3 2022

Nov 10, 2022
SELL
$161.33 - $179.52 $88,570 - $98,556
-549 Reduced 0.22%
249,715 $40.8 Million
Q2 2022

Jul 29, 2022
SELL
$168.19 - $186.01 $227,392 - $251,485
-1,352 Reduced 0.54%
250,264 $44.4 Million
Q1 2022

May 12, 2022
BUY
$158.14 - $179.59 $133,786 - $151,933
846 Added 0.34%
251,616 $44.6 Million
Q4 2021

Feb 04, 2022
BUY
$155.93 - $173.01 $1.16 Million - $1.29 Million
7,443 Added 3.06%
250,770 $42.9 Million
Q3 2021

Oct 25, 2021
BUY
$161.5 - $179.47 $839,154 - $932,526
5,196 Added 2.18%
243,327 $39.3 Million
Q2 2021

Aug 13, 2021
BUY
$159.48 - $171.07 $879,213 - $943,108
5,513 Added 2.37%
238,131 $39.2 Million
Q1 2021

May 05, 2021
BUY
$153.07 - $170.48 $838,364 - $933,718
5,477 Added 2.41%
232,618 $38.2 Million
Q4 2020

Feb 11, 2021
BUY
$137.11 - $157.38 $256,395 - $294,300
1,870 Added 0.83%
227,141 $35.7 Million
Q3 2020

Nov 12, 2020
BUY
$140.38 - $153.83 $14,318 - $15,690
102 Added 0.05%
225,271 $33.5 Million
Q2 2020

Aug 14, 2020
BUY
$128.81 - $155.51 $502,101 - $606,177
3,898 Added 1.76%
225,169 $31.7 Million
Q1 2020

May 13, 2020
BUY
$111.14 - $153.99 $160,819 - $222,823
1,447 Added 0.66%
221,271 $29 Million
Q4 2019

Feb 12, 2020
BUY
$127.5 - $146.44 $574,642 - $660,005
4,507 Added 2.09%
219,824 $32.1 Million
Q3 2019

Nov 13, 2019
BUY
$126.95 - $142.14 $1.05 Million - $1.17 Million
8,257 Added 3.99%
215,317 $27.9 Million
Q2 2019

Jul 19, 2019
SELL
$131.15 - $144.24 $190,560 - $209,580
-1,453 Reduced 0.7%
207,060 $28.8 Million
Q1 2019

May 01, 2019
BUY
$125.72 - $139.79 $301,979 - $335,775
2,402 Added 1.17%
208,513 $29.1 Million
Q4 2018

Feb 05, 2019
SELL
$122.84 - $147.84 $343,337 - $413,212
-2,795 Reduced 1.34%
206,111 $26.6 Million
Q3 2018

Nov 07, 2018
BUY
$121.58 - $142.88 $548,082 - $644,103
4,508 Added 2.21%
208,906 $28.9 Million
Q2 2018

Jul 31, 2018
BUY
$119.4 - $131.76 $535,509 - $590,943
4,485 Added 2.24%
204,398 $24.8 Million
Q1 2018

Apr 05, 2018
BUY
$125.1 - $148.14 $336,268 - $398,200
2,688 Added 1.36%
199,913 $25.6 Million
Q4 2017

Feb 09, 2018
BUY
$131.22 - $143.62 $95,134 - $104,124
725 Added 0.37%
197,225 $27.6 Million
Q3 2017

Nov 09, 2017
BUY
$129.47 - $135.38 $406,017 - $424,551
3,136 Added 1.62%
196,500 $25.5 Million
Q2 2017

Aug 11, 2017
BUY
N/A
193,364
193,364 $25.6 Million

Others Institutions Holding JNJ

# of Institutions
4,275
Shares Held
1.68B
Call Options Held
17.6M
Put Options Held
14.5M
View Full List

About JOHNSON & JOHNSON

JNJ Quotes by TradingView
  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $383B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Destination Wealth Management Portfolio

Follow Destination Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Destination Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Destination Wealth Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email